In partnership with
December 24, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Christmas Eve edition, and we kept it simple: what the industry should be asking Santa for that isn’t a useless white elephant gift or won’t have you looking for the gift receipt. Today’s edition is supported by 1440 Media and The Deep View. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
🎄 Schedule III that sticks
🎁 Federal hemp framework
🛂 Compliance passport
Happy Holidays to you and your family. Thanks for reading.
Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.
Start here — the day’s most important development, decoded for impact.
What The Industry Should Be Asking Santa For This Year
Cannabis has spent years getting the same holiday gifts from Washington. An unironic ugly sweater in the wrong size, a vague promise to exchange it later, and a drunk uncle at the table explaining how this will all be “sorted out soon.”
First, a finished Schedule III move with an effective date that survives the first courtroom sprint. A tax break that gets stayed is the ultimate white elephant. You unwrap it, you smile, and then someone quietly takes it back before New Year’s.
Second, a federal hemp framework that stops punishing the responsible cousin for the chaos gremlin. Protect disciplined, age-gated low-dose products with defined serving sizes and testing. Put converted cannabinoids and youth-access retail on the naughty list so lawmakers stop treating the whole category like the black sheep.
Third, a national compliance passport. This is the boring present you pretend you hate but you actually needed and use everyday. Dad’s new socks and underwear. New tires. A targeted federal safe harbor tied to auditable controls: chain-of-custody, testing discipline, tax compliance, age-gating. If you can prove those controls, the normal economy gets permission to treat you like a real customer. Banks, payments, insurance, payroll, and the vendors that keep a business upright can finally work with you without treating every contract like a massive favor. That is how cannabis graduates from workaround economy to normal regulated commerce.
Fourth, a banking fix framed as public safety, not moral approval. Cash-heavy commerce invites risk and forces everyone into workarounds. Treat it like the security problem it is and you will see immediate impact.
Fifth, enforcement capacity that actually shows up. Rules without inspections are the office Secret Santa mug. Everyone pretends it is useful, and it sits in a cabinet forever. Bad actors count on that.
If Santa delivers even two of these, the industry might finally stop asking for gift receipts.
Fast-moving headlines, flagged for what matters.
A Schedule II fallback surfaced in an Oval Office meeting this month, and Scotts Miracle-Gro CEO Jim Hagedorn says President Trump rejected it and insisted on Schedule III. Hagedorn told NewsNation the president framed Schedule III as the only move worth making. Schedule II would have left 280E in place, keeping state-legal businesses stuck with punitive effective tax rates. Schedule III opens the door to ordinary deductions once a final rule becomes effective. That puts the administrative record and early litigation posture at the center of the next phase. (Marijuana Moment)
The Marijuana Herald reports that President Trump told Attorney General Pam Bondi to finalize rescheduling by the end of January, citing unnamed sources close to the president. The executive order language calls for speed and directs DOJ to follow federal law, and it does not publish a hard deadline. A January finish would require rapid procedural moves, including resolving the hearing posture, finalizing the record, and publishing a final rule that can withstand an immediate stay request. Businesses can model 280E relief, yet the tax change stays locked until the rule is effective and survives early litigation. Concrete markers are the public docket, any hearing notices, and the Federal Register publication timeline. (The Marijuana Herald)
New filings and public records show cannabis interests and allies poured money into Trump-linked political channels in the months leading up to the rescheduling executive order. The Washington Examiner reports at least $2 million in donations to committees tied to Trump after the 2024 election, including a $1 million contribution from American Rights and Reform PAC to MAGA Inc. and another $1 million routed to the Trump Vance Inaugural Committee from Trulieve and the U.S. Cannabis Council. The same review cites lobbying disclosures totaling roughly $3.2 million in industry spending. Opponents will use this as narrative fuel in oversight and litigation, and that raises the premium on clean agency reasoning and careful record building. The rule’s durability will turn on process and evidence, not political theater. (Washington Examiner)
Rescheduling to Schedule III changes tax posture and research posture, and it leaves federal legality untouched for state adult-use commerce. 280E relief only arrives after a final rule is published and becomes effective. That timing gap keeps feeding fantasies about interstate commerce, FDA pathways, and exchange listings that the statute does not deliver. The next phase runs through administrative procedure, with agencies building a record designed to survive a stay request on day one. Every serious 2026 plan still needs a timing-slips scenario. (National Law Review)
Maine’s Office of Cannabis Policy says federal rescheduling will not change how the state runs medical and adult-use cannabis. State programs already operate in tension with federal law, and that tension continues under Schedule III. The compliance baseline in Augusta stays the same while the federal fight shifts to taxes, research, and procedure. The budgeting work for 2026 can proceed without state rule rewrites or emergency guidance. Washington still controls the ceiling until a final rule becomes effective and survives early litigation. (Maine Public)
A High Times essay pushes back on the market chatter that Schedule III unlocks NYSE or Nasdaq uplisting for U.S. plant-touching businesses. Rescheduling does not legalize cultivation, distribution, or retail under federal law, so exchange and custody constraints remain. The closest near-term change is 280E relief once a final rule becomes effective, which keeps timing at the center of capital planning. The piece also argues that reform debates narrow when they are filtered through tickers and trading narratives. Public-company strategy still has to start with federal illegality and administrative process. (High Times)
Federal survey data show teen marijuana use stayed broadly stable in 2025 even as legalization expanded. Past-year use came in at 26% for 12th graders, 16% for 10th graders, and 8% for 8th graders, with abstention rates holding near historic highs. The same dataset highlights hemp-derived intoxicants, with 9% of 12th graders reporting past-year use of hemp-based cannabis products that can include delta-8 THC. That split matters because age-gated cannabis retail and disciplined low-dose beverage models rely on ID checks and traceable supply chains, while hemp-derived products have often moved through weaker channels. Youth protection will turn on channel rules and enforcement capacity. (Marijuana Moment)
Missouri lawmakers are heading into January with a federal change already shaping contracts and political posture: a spending bill rewrote the hemp definition and adds a 0.4 milligram total THC cap per container for finished products, effective next November. Some prefiled bills track that shift and would treat intoxicating hemp like marijuana, pushing products into dispensaries and sidelining the current retail footprint. Other proposals keep a non-dispensary lane through registration and state rulemaking, even though they were drafted before the federal language landed. The uncertainty is already bleeding into banking, payments, and vendor relationships, with service providers signaling they may exit ahead of the effective date. The session fight turns on a concrete choice between an age-gated, low-dose framework with real guardrails and a forced migration into marijuana rules. (Missouri Independent)
Michigan Senate bills heading to the House would draw a bright line at 1.75 milligrams of THC per container, treating anything above that as marijuana that belongs in the licensed dispensary system. Sponsors argue the goal is enforceability and youth protection, with a focus on products sold through convenience-style retail. Hemp industry voices argue the threshold is too low and could squeeze legitimate CBD products that need higher milligram totals to meet consumer expectations. Lawmakers also shifted from a per-serving limit to a per-container limit to stop multi-serving packages from skating past the intent. The House now has to reconcile this approach with an incoming federal per-container cap and the policy case for a disciplined, age-gated beverage lane. (Michigan Public)
Michigan’s leading cannabis trade group is appealing a Court of Claims ruling that left a new 24% wholesale excise tax in place, with the tax scheduled to start January 1st. The levy was enacted in October as part of a road funding package, and Treasury guidance layers it on top of the existing 10% adult-use excise tax and 6% sales tax. The court leaned on voter initiative language that contemplates additional taxes, and the industry says lawmakers effectively rewrote the 2018 framework without meeting the constitutional bar for changing a citizen initiative. Pricing decisions are landing now because wholesale terms and January invoices will set the market baseline. Once the shelf price resets upward, political pressure builds in both directions. (The Detroit News)
Minnesota has a crowding problem, with 1,138 cannabis businesses holding preliminary approval while entrepreneurs scramble for compliant storefronts. State data cited in local reporting shows 41 dispensaries already open and 56 more with full microbusiness approval that still have not launched. Regulators have closed new dispensary applications and given preliminarily approved applicants 18 months to reach full licensure, which creates a long runway for financing and municipal friction to decide who survives. Supply remains thin, with product largely coming from tribal nations and two medical manufacturers while cultivation scales slowly. The first shakeout will come from shelves and leases, not social media presence. (FOX 9)
Smart Approaches to Marijuana says it is backing ballot efforts that would end adult-use cannabis sales in both Maine and Massachusetts. The proposals keep adult possession legal while shifting lawful sales back toward medical channels, a move that would unwind roughly $1.6 billion in annual Massachusetts sales and close in on $300 million in Maine. In Massachusetts, organizers face allegations that some signature gatherers misled voters about what they were signing, and the funding picture will sharpen as campaign filings arrive. In Maine, election officials have cleared the petition to begin collecting signatures, putting a real clock on qualification. If a repeal qualifies, underwriting changes quickly and leases become harder to finance. (MJBizDaily)
New Jersey and Virginia regulators are using the holiday crush to push straightforward compliance reminders for consumers. New Jersey’s Cannabis Regulatory Commission rolled out a S.M.A.R.T. safe-use campaign focused on storage, mindful dosing, and keeping products away from kids. Virginia’s Cannabis Control Authority emphasized impaired-driving prevention and urged people to plan a sober ride before the first bite, sip, or puff. The legal fault lines stay consistent: cannabis stays in-state, products stay secured, and driving enforcement stays active. Holiday travel has a way of turning casual choices into citations. (Marijuana Moment)
The New York Yankees are defending their interlocking N and Y logo against a cannabis apparel seller seeking to register a similar mark for hats and other clothing. The Trademark Trial and Appeal Board already sided with the Yankees, finding the nested design dominates even when the applicant adds cannabis leaves and the words New York Cannabis. The Board treated those add-ons as descriptive rather than source-identifying, and it credited the Yankees’ fame in assessing likely confusion. The appeal tees up a familiar lesson for cannabis-adjacent merch: borrowing iconic geometry rarely survives when the underlying mark is a cultural institution. A win here tightens the lane for lifestyle brands that lean on sports trade dress instead of building their own. (Law360)
Stop Drowning In AI Information Overload
Your inbox is flooded with newsletters. Your feed is chaos. Somewhere in that noise are the insights that could transform your work—but who has time to find them?
The Deep View solves this. We read everything, analyze what matters, and deliver only the intelligence you need. No duplicate stories, no filler content, no wasted time. Just the essential AI developments that impact your industry, explained clearly and concisely.
Replace hours of scattered reading with five focused minutes. While others scramble to keep up, you'll stay ahead of developments that matter. 600,000+ professionals at top companies have already made this switch.
From the hearing room to the comment section — we’re watching it all.
🩺 New Jersey’s medical cannabis patient roster kept sliding in 2025, falling from 65,433 in January to 51,776 by mid-December, a drop of about 21%. Adult-use availability keeps pulling casual patients out of the registry, which tightens the medical market and forces the state to decide whether medical is a protected access lane or a legacy program left to shrink. (New Jersey Monitor)
🪪 Undercover purchase attempts in the Twin Cities found hemp-derived THC products were sold without ID checks more than half the time, including at many stores that already sell age-restricted products. That kind of compliance failure hands lawmakers their favorite villain and drags disciplined low-dose products into the same penalty box as slapdash retail. (MinnPost)